-
Jun 21, 2023, 10:34 AM
by
Full story
-
Jun 21, 2023, 01:00 AM
by
User Not Found
Bio-IT World | At the Bio-IT World Conference & Expo last month, members of the Genomics England team shared about the organization’s history, vision, and what it’s working on now.
Full story
-
Jun 20, 2023, 10:56 AM
by
CluePoints, Ken Getz & Tufts CSDD and PwC Unveil New RBQM Insights Report at DIA Global Annual Meeting 2023
CluePoints and partners present and discuss the results of a new study examining RBQM use and adoption.
Full story
-
Jun 20, 2023, 10:56 AM
by
Full story
-
Jun 20, 2023, 10:56 AM
by
Full story
-
Jun 20, 2023, 10:56 AM
by
Amerigo Scientific launches its ultra-low temperature freezers with a temperature range from -40°C to -86°C.
Full story
-
Jun 20, 2023, 10:56 AM
by
Full story
-
Jun 20, 2023, 10:56 AM
by
Huateng Pharma is a leading and professional manufacturer which can provide pharmaceutical intermediates, PEG derivatives, biochemical reagents, APIs, Vitamin D Derivatives and so on. We have a 34,000 square meter manufacturing site with advanced design concept of intelligent manufacturing, which can realize the integration of the production process and accomplish the complete transformation of lab scale - pilot plant - large-scale commercial production, with an annual capacity of more than 1 billion RMB.
Full story
-
Jun 16, 2023, 11:17 AM
by
Full story
-
Jun 16, 2023, 11:17 AM
by
Full story
-
Jun 16, 2023, 09:58 AM
by
Torx® Software Limited, announces the release of Torx 2.0, extending the platform’s scientific reach and capabilities to deliver unrivalled seamless integration across the drug discovery Design-Make-Test-Analyze (DMTA) cycle.
Full story
-
Jun 16, 2023, 09:58 AM
by
Creative Biolabs released exhibition highlight moments from their booth 2548 at the 2023 BIO International Convention held from June 5 to 8.
Full story
-
Jun 16, 2023, 09:57 AM
by
Full story
-
Jun 16, 2023, 09:57 AM
by
Full story
-
Jun 16, 2023, 09:57 AM
by
Full story
-
Jun 16, 2023, 09:56 AM
by
PhenoTips announces the appointment of Dr. Pawel Buczkowicz as Chief Executive Officer. This decision follows Dr. Orion Buske stepping down from the position of CEO, a role he has held since 2018, and returning in a senior leadership role in the coming months. The Canada-based software company and producer of the world’s first Genomic Health Record will see Dr. Buczkowicz take over the role of CEO and further the company’s trajectory towards widespread adoption, enabling global digital data unification and standardization in genomic medicine.
Full story
-
Jun 16, 2023, 01:00 AM
by
User Not Found
Bio-IT World | As the life sciences industry continues to grow and innovate, it is critical for labs to leverage automation technology to reduce manual workload and unlock new avenues for scientific discovery. With breakthroughs in gene-editing, increased healthcare testing, and genomic surveillance due to the COVID-19 pandemic, labs cannot afford to have highly qualified scientists tied to their benches performing easily automatable tasks.
Full story
-
Jun 15, 2023, 10:22 AM
by
NCC Group, one of the world’s largest cybersecurity consulting firms, has collaborated with the Department for Transport and the Transport Technology Forum to develop the Manual for Smart Streets, a newly launched guide for UK authorities and other key stakeholders in road infrastructure.
It supports authorities who are conceiving, designing and implementing smart street systems in the UK, and was created to provide guidance, examples and practical pointers, allowing them to make best use of technology and improve how the UK travels.
Full story
-
Jun 15, 2023, 09:30 AM
by
MIB Agents, a leading pediatric osteosarcoma nonprofit dedicated to Making It Better for its community of patients, caregivers, doctors, and researchers, announced today that since its inception in 2016, it has awarded over $1.5 million to scientists across the country through its OutSmarting Osteosarcoma grant program. The OutSmarting Osteosarcoma grants are supported by MIB Agents Family Funds, osteosarcoma patients and families who raise funds in honor of an OsteoWarrior, a patient currently battling osteosarcoma or an OsteoAngel, a loved one who has passed.
Full story
-
Jun 14, 2023, 10:14 AM
by
The global cancer gene therapy industry size accounted for USD 2.04 billion in 2022 and is estimated to achieve a market size of USD 12.75 billion by 2032 growing at a CAGR of 20.1% from 2023 to 2032.
Full story